Similarly, an increase of antigen-specific CD8 T cells that express PD-1, but not Tim-3, has been found in the tumor microenvironment after PD-1/CTLA-4 checkpoint blockade therapy (9, 19). This evidence concerns the gene CTLA4 and neoplasm.